AI
ELOX

Atom Investors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Atom Investors’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,638
Closed -$51.2K – 575
2023
Q3 		$51.2K Buy
+10,638
New +$59.6K 0.01% 412
2022
Q4 		– Sell
-3,603
Closed -$24K – 364
2022
Q3 		$24K Buy
3,603
+375
+12% +$4.51K 0.01% 270
2022
Q2 		$35K Buy
3,228
+399
+14% +$5.51K 0.02% 239
2022
Q1 		$63K Hold
2,829
– – 0.03% 182
2021
Q4 		$80K Buy
+2,829
New +$123K 0.01% 247

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Atom Investors's ELOX Position: Q4 2023 in Review

Atom Investors sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 10,638 shares — an estimated $51.2K sold.

Atom Investors first reported a position in ELOX in Q4 2021 and held it in 5 quarters. The position peaked at $80K in Q4 2021. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Atom Investors reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Atom Investors sold 10,638 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $51.2K.
  • Atom Investors first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Atom Investors's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $80K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Atom Investors's 13F filing for Q4 2023, filed 14 Feb 2024.